Brian Salmons, Eva M Brandtner, Kay Hettrich, Wolfgang Wagenknecht, Bert Volkert, Steffen Fischer, John A Dangerfield, Walter H Gunzburg
One of the first strategies for cancer gene therapy was the use of suicide gene/prodrug combinations, originally delivered to tumor cells using viral vectors. A major limitation of this approach was the inefficiency of suicide gene delivery. An alternative strategy, in which the suicide genes are physically juxtaposed to the tumor, involves the implantation of encapsulated, genetically modified cells. Cell encapsulation technologies were originally developed for the treatment of acquired and genetic diseases, such as diabetes...
August 2010: Current Opinion in Molecular Therapeutics